Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Pfizer-LABS: 1 winner so far out of the 20+ strong clinical

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Oct 25, 2023 11:31am

115 Views

Post# 35700180

RE:Pfizer-LABS: 1 winner so far out of the 20+ strong clinical

Can you elaborate on the term "partner"? If LABS has the only certification for APIs and any drugs made with cannabis extractions have to be purchased through LABS as you stated, be it Pfizer, Tilray, Apotex, or whoever, then I don't see a partnership being a financial advantage any more than any other client if the model is white label APIs.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide